nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—GRIN2D—Alzheimers Disease—TNF—osteoarthritis	0.00171	0.00171	CbGpPWpGaD
Ketamine—GRIN1—Alzheimers Disease—IL1B—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—MMP9—osteoarthritis	0.00168	0.00168	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—COL9A2—osteoarthritis	0.00167	0.00167	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—COL9A1—osteoarthritis	0.00167	0.00167	CbGpPWpGaD
Ketamine—GRIN2B—Alzheimers Disease—IL1B—osteoarthritis	0.00165	0.00165	CbGpPWpGaD
Ketamine—SLC6A2—Monoamine Transport—TNF—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—COL9A1—osteoarthritis	0.00162	0.00162	CbGpPWpGaD
Ketamine—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—IHH—osteoarthritis	0.00155	0.00155	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Ketamine—GRIN2A—Alzheimers Disease—TNF—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Ketamine—GRIN1—EPH-Ephrin signaling—MMP9—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—TGFB1—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Ketamine—GRIN2B—EPH-Ephrin signaling—MMP9—osteoarthritis	0.00135	0.00135	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—GSTO1—osteoarthritis	0.00135	0.00135	CbGpPWpGaD
Ketamine—CYP2B6—Metapathway biotransformation—GSTO1—osteoarthritis	0.00133	0.00133	CbGpPWpGaD
Ketamine—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00132	0.00132	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—PTGS2—osteoarthritis	0.00132	0.00132	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—TNF—osteoarthritis	0.00129	0.00129	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—CXCL8—osteoarthritis	0.00128	0.00128	CbGpPWpGaD
Ketamine—TACR1—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.00127	0.00127	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Ketamine—GRIN1—Alzheimers Disease—TNF—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—IL1B—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Ketamine—GRIN2B—Alzheimers Disease—TNF—osteoarthritis	0.0012	0.0012	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—MCF2L—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—IHH—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—MMP9—osteoarthritis	0.00116	0.00116	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	0.00114	0.00114	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IHH—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MCF2L—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Ketamine—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IHH—osteoarthritis	0.00108	0.00108	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MCF2L—osteoarthritis	0.00108	0.00108	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—IL6—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—MCF2L—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.000982	0.000982	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000964	0.000964	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TGFB1—osteoarthritis	0.000954	0.000954	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MCF2L—osteoarthritis	0.000943	0.000943	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IHH—osteoarthritis	0.000943	0.000943	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.00093	0.00093	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—IL1B—osteoarthritis	0.000923	0.000923	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.000922	0.000922	CbGpPWpGaD
Ketamine—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000917	0.000917	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TNF—osteoarthritis	0.000891	0.000891	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—MCF2L—osteoarthritis	0.000878	0.000878	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.000871	0.000871	CbGpPWpGaD
Ketamine—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000855	0.000855	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.000851	0.000851	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000842	0.000842	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.000834	0.000834	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—COL9A2—osteoarthritis	0.000828	0.000828	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—COL9A1—osteoarthritis	0.000804	0.000804	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MCF2L—osteoarthritis	0.000797	0.000797	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IHH—osteoarthritis	0.000797	0.000797	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000784	0.000784	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—IL6—osteoarthritis	0.000719	0.000719	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—TGFB1—osteoarthritis	0.000717	0.000717	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—SMAD3—osteoarthritis	0.000717	0.000717	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.000714	0.000714	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.000713	0.000713	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—SMAD3—osteoarthritis	0.000699	0.000699	CbGpPWpGaD
Ketamine—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000696	0.000696	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP2—osteoarthritis	0.000686	0.000686	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP2—osteoarthritis	0.000669	0.000669	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—MCF2L—osteoarthritis	0.000665	0.000665	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—CXCL8—osteoarthritis	0.000648	0.000648	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—MMP3—osteoarthritis	0.000647	0.000647	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000645	0.000645	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MCF2L—osteoarthritis	0.000636	0.000636	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IHH—osteoarthritis	0.000636	0.000636	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.000626	0.000626	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000623	0.000623	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.000613	0.000613	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—LEP—osteoarthritis	0.000613	0.000613	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.000605	0.000605	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IHH—osteoarthritis	0.000604	0.000604	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MCF2L—osteoarthritis	0.000604	0.000604	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—CXCL8—osteoarthritis	0.000603	0.000603	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—LEP—osteoarthritis	0.000597	0.000597	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—LEP—osteoarthritis	0.000577	0.000577	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.000575	0.000575	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	0.000569	0.000569	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MCF2L—osteoarthritis	0.000557	0.000557	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IHH—osteoarthritis	0.000557	0.000557	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—BMP2—osteoarthritis	0.000551	0.000551	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—IL6—osteoarthritis	0.000541	0.000541	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.000529	0.000529	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—CXCL8—osteoarthritis	0.000528	0.000528	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—FMOD—osteoarthritis	0.000527	0.000527	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—TGFB1—osteoarthritis	0.000519	0.000519	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP9—osteoarthritis	0.000516	0.000516	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000507	0.000507	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP9—osteoarthritis	0.000503	0.000503	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.000501	0.000501	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP2—osteoarthritis	0.00049	0.00049	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.000481	0.000481	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.000479	0.000479	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP2—osteoarthritis	0.000478	0.000478	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MCF2L—osteoarthritis	0.000471	0.000471	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IHH—osteoarthritis	0.000471	0.000471	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—COL9A2—osteoarthritis	0.000466	0.000466	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	0.000459	0.000459	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—COL9A1—osteoarthritis	0.000453	0.000453	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—CXCL8—osteoarthritis	0.000447	0.000447	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGES—osteoarthritis	0.000429	0.000429	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00042	0.00042	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—COL9A2—osteoarthritis	0.000409	0.000409	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—FMOD—osteoarthritis	0.000402	0.000402	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—COL9A1—osteoarthritis	0.000397	0.000397	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP3—osteoarthritis	0.000382	0.000382	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000374	0.000374	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP9—osteoarthritis	0.000368	0.000368	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000366	0.000366	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—CXCL8—osteoarthritis	0.000365	0.000365	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MMP3—osteoarthritis	0.000364	0.000364	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP9—osteoarthritis	0.000359	0.000359	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MCF2L—osteoarthritis	0.000357	0.000357	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IHH—osteoarthritis	0.000357	0.000357	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000355	0.000355	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.000355	0.000355	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.000349	0.000349	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—COL9A2—osteoarthritis	0.000346	0.000346	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SMAD3—osteoarthritis	0.000346	0.000346	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—FMOD—osteoarthritis	0.00034	0.00034	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—CXCL8—osteoarthritis	0.000338	0.000338	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—COL9A1—osteoarthritis	0.000336	0.000336	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—CXCL8—osteoarthritis	0.000332	0.000332	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGES—osteoarthritis	0.000328	0.000328	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—IL6—osteoarthritis	0.00032	0.00032	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—CXCL8—osteoarthritis	0.00032	0.00032	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MMP3—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—IL6—osteoarthritis	0.000312	0.000312	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—BMP2—osteoarthritis	0.00031	0.00031	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000307	0.000307	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TGFB1—osteoarthritis	0.000303	0.000303	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTO1—osteoarthritis	0.000303	0.000303	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—FMOD—osteoarthritis	0.000296	0.000296	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TGFB1—osteoarthritis	0.000296	0.000296	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—LEP—osteoarthritis	0.000295	0.000295	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—BGN—osteoarthritis	0.000293	0.000293	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TNF—osteoarthritis	0.000283	0.000283	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ESR1—osteoarthritis	0.000282	0.000282	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—FN1—osteoarthritis	0.000279	0.000279	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000277	0.000277	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—FMOD—osteoarthritis	0.000277	0.000277	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—osteoarthritis	0.000276	0.000276	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—BMP2—osteoarthritis	0.000272	0.000272	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—CXCL8—osteoarthritis	0.00027	0.00027	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MMP3—osteoarthritis	0.00027	0.00027	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.000269	0.000269	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—COL9A2—osteoarthritis	0.000262	0.000262	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000255	0.000255	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—COL9A1—osteoarthritis	0.000254	0.000254	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IGF1—osteoarthritis	0.000244	0.000244	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGES—osteoarthritis	0.000242	0.000242	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTO1—osteoarthritis	0.000231	0.000231	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BMP2—osteoarthritis	0.00023	0.00023	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—IL6—osteoarthritis	0.000229	0.000229	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGES—osteoarthritis	0.000226	0.000226	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—BGN—osteoarthritis	0.000224	0.000224	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—IL6—osteoarthritis	0.000223	0.000223	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—IL6—osteoarthritis	0.000215	0.000215	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP3—osteoarthritis	0.000215	0.000215	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000206	0.000206	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CXCL8—osteoarthritis	0.000205	0.000205	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MMP3—osteoarthritis	0.000205	0.000205	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CXCL8—osteoarthritis	0.000196	0.000196	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTO1—osteoarthritis	0.000195	0.000195	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SMAD3—osteoarthritis	0.000195	0.000195	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—BGN—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP3—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CXCL8—osteoarthritis	0.000187	0.000187	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL6—osteoarthritis	0.000187	0.000187	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000184	0.000184	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000183	0.000183	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000181	0.000181	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP9—osteoarthritis	0.000178	0.000178	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BMP2—osteoarthritis	0.000174	0.000174	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000172	0.000172	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SMAD3—osteoarthritis	0.000171	0.000171	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTO1—osteoarthritis	0.00017	0.00017	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—LEP—osteoarthritis	0.000166	0.000166	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BGN—osteoarthritis	0.000165	0.000165	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CXCL8—osteoarthritis	0.000164	0.000164	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP3—osteoarthritis	0.000159	0.000159	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTO1—osteoarthritis	0.000159	0.000159	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ESR1—osteoarthritis	0.000159	0.000159	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FN1—osteoarthritis	0.000157	0.000157	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BGN—osteoarthritis	0.000154	0.000154	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000153	0.000153	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000149	0.000149	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TGFB1—osteoarthritis	0.000146	0.000146	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—LEP—osteoarthritis	0.000146	0.000146	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SMAD3—osteoarthritis	0.000144	0.000144	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ESR1—osteoarthritis	0.000139	0.000139	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCL8—osteoarthritis	0.000139	0.000139	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FN1—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—LEP—osteoarthritis	0.000123	0.000123	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000122	0.000122	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP3—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ESR1—osteoarthritis	0.000118	0.000118	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FN1—osteoarthritis	0.000116	0.000116	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL8—osteoarthritis	0.000116	0.000116	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL8—osteoarthritis	0.000111	0.000111	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—osteoarthritis	0.00011	0.00011	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SMAD3—osteoarthritis	0.000109	0.000109	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—osteoarthritis	0.000105	0.000105	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL8—osteoarthritis	0.000105	0.000105	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000105	0.000105	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BGN—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—osteoarthritis	0.0001	0.0001	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	9.95e-05	9.95e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL8—osteoarthritis	9.7e-05	9.7e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LEP—osteoarthritis	9.35e-05	9.35e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—osteoarthritis	9.22e-05	9.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ESR1—osteoarthritis	8.92e-05	8.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FN1—osteoarthritis	8.81e-05	8.81e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—osteoarthritis	8.77e-05	8.77e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—osteoarthritis	8.43e-05	8.43e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—osteoarthritis	8.24e-05	8.24e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—osteoarthritis	8.2e-05	8.2e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—osteoarthritis	7.79e-05	7.79e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—osteoarthritis	7.72e-05	7.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—osteoarthritis	7.41e-05	7.41e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—osteoarthritis	7.23e-05	7.23e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—osteoarthritis	6.43e-05	6.43e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—osteoarthritis	6.21e-05	6.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—osteoarthritis	6.21e-05	6.21e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—osteoarthritis	6.11e-05	6.11e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—osteoarthritis	5.91e-05	5.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—osteoarthritis	5.62e-05	5.62e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—osteoarthritis	5.45e-05	5.45e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—osteoarthritis	5.44e-05	5.44e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—osteoarthritis	4.74e-05	4.74e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—osteoarthritis	4.63e-05	4.63e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—osteoarthritis	4.6e-05	4.6e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—osteoarthritis	4.43e-05	4.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—osteoarthritis	3.49e-05	3.49e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—osteoarthritis	2.92e-05	2.92e-05	CbGpPWpGaD
